PURPOSE
Rituximab is widely used off-label as a lower-cost alternative to ocrelizumab for relapsing multiple sclerosis (MS), but comparative effectiveness and safety remain uncertain. We assessed direct head-to-head evidence and concordance between randomized and real-world findings.
METHODS
PubMed/MEDLINE, Cochrane...
Yehia Nabil, Ahmed Shaheen, Anas Mansour et al.· Multiple Sclerosis and Relat...· 0 citations
PURPOSE
Transcranial alternating current stimulation (tACS) may modulate neural oscillations implicated in major depressive disorder (MDD). This systematic review and meta-analysis assessed the efficacy, follow-up effects, tolerability, and safety of tACS in adults with MDD.
METHODS
PubMed/MEDLINE, CENTRAL, Scopus, W...
Yehia Nabil, Khaled Moghib, Zeyad Tarek et al.· Journal of Affective Disorde...· 0 citations
Telmisartan-based regimens, particularly fixed-dose and multidrug combinations, effectively reduce office and ambulatory blood pressure and improve blood pressure response, with broadly comparable short-term safety and less edema.
B. A. Alsel, Muzun Saleh Alturqi Alanazi, Aryam Salem Mgairan Alrawaili et al.· BMC Cardiovascular Disorders· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.